Previous group members
DR CLARE STEVENSON, PhD, 1995-1998. Went on to be a medicinal organic chemist at Albany Molecular (NY state, US).
DR PAUL GUYO, PhD, 1995-1998. Did a postdoc with George Olah- Nobel Laureate (Los Angeles, US) and went on to be a synthetic organic chemist with AstraZeneca.
DR MIKE WARING, PhD, 1996-1999. Did a postdoc with Phil Magnus (Texas, US) and went on to be a medicinal organic chemist with AstraZeneca.
DR RAKESH HARJI, PhD, 1996-1999. Started as a synthetic organic chemist with AstraZeneca: he went on to be a patent attorney with AstraZeneca.
DR JON WINTER, PhD, 1997-2000. Went on to be a medicinal organic chemist with AstraZeneca.
DR KEVIN BLADES, postdoc, 1997-2000. Went on to be a synthetic organic chemist with AstraZeneca.
DR KARL ACE, PhD, 1997-2000. Did a postdoc with J. Sutherland (Manchester) and then worked as a production chemist for GlaxoSmithKline.
DR ANDREW McRINER, PhD, 1997-2000. Went on to be a medicinal organic chemist with Novartis (New Jersey, US).
DR ANDREW CALABRESE, postdoc, 1999-2001. Went on to be a medicinal organic chemist with Pfizer.
DR ALI RAOOF, PhD, 2002. Went on to be a synthetic organic chemist with Evotec OAI (Abingdon).
DR LEE MITCHELL, PhD, 1999-2001. Did a postdoc with Professor N. Simpkins (Nottingham).
DR J-B. GUILLERMIN, PhD, 1999-2001. Did a postdoc with Professor P. Grieco (Montana, US).
DR DAVID HOUSE, postdoc, 2000-2002. Went on to be a medicinal organic chemist with GlaxoSmithKline.
DR CATHERINE HEADLEY, PhD, 1999-2002. Did a postdoc wth Dr. S. Marsden (Leeds).
DR JAMES LOGAN, PhD, 1999-2002. Went on to be a synthetic organic chemist with Almac Sciences Limited.
DR LAURA MACE, PhD, 2000-2003. Did a postdoc with Professor J. White (Oregon State University, US) and then worked as a process research chemist with GlaxoSmithKline (Tonbridge).
DR PETER JOHNSON, PhD, 2000-2003. Did a postdoc with Professor V. Rawal (University of Chicago) and went on to be a medicinal organic chemist with VastOx (Oxford).
DR F. TURNER, PhD, 2000-2003. Went on to be a synthetic organic chemist with Ferring Ltd (Southampton).
DR DAVID CARBERY, postdoc 2003. Did another postdoc with Alan Armstrong (Imperial College) and went on to be a Lecturer in Organic Chemistry at the University of Bath.
DR R. PYE, postdoc, 2002-2004. Is currently a medicinal organic chemist with VastOx (Oxford).
DR H. SINTIM, postdoc, 2002-2004. Did a postdoc with Eric Kool (Stanford) and went on to be an Associate Professor of Chemistry at the University of Maryland (US).
DR SAM BUTTERWORTH, DPhil, 2001-2004. Is currently a medicinal organic chemist with AstraZeneca.
DR GRAEME FREESTONE, PhD, 2001-2004. Went on to be a postdoc with K. C. Nicolaou (Scripps, California).
DR PETER TURNER, PhD, 2002-2005. Went on to be a process research chemist with GlaxoSmithKline (Stevenage).
DR ALAN IRONMONGER, postdoc, 2005-06. Went on to be a process research chemist with GlaxoSmithKline (Tonbridge).
DR CAROLINE RIGBY, PhD, 2002-2005. Went on to be a research chemist at Peakdale Molecular.
DR MAJID CHUGHTAI, PhD, 2002-2005. Went on to work for Shell as a research chemist.
DR ROBERT HARRIS, PhD, 2003-2006. Went on to be a process research chemist with GlaxoSmithKline (Stevenage).
DR DALE JOHNSON, PhD, 2003-2006. Went on to be a medicinal chemist with GlaxoSmithKline (Harlow).
DR PAOLO INNOCENTI, postdoc, 2006-2007. Went on to be a research chemist at Dextra.
DR CAROLE BATAILLE, postdoc, 2005-2007. Did a postdoc in Prof. Steve Davies's group (Oxford).
DR GWYDIAN CHURCHILL, postdoc, 2005-2007. Went on to be a Process Chemist with AstraZeneca.
DR FATIMA CHURRUCA, postdoc, 2005-2007.
DR DAVID KLAUBER, PhD, 2004-2007. Went on to be a process research chemist with AstraZeneca.
DR RHIAN THOMAS, PhD, 2004-2007. Went on to be a postdoc in Dr Martin Smith's group (Oxford).
DR FARRAH BHATTI, PhD, 2004-2007. Went on to work for the Royal Society of Chemistry.
DR MATTHEW CHEESEMAN, 2006-2008. Went on to be a medicinal chemist with the Institute of Cancer Research (Sutton)
DR LISA FISHLOCK, PhD, 2005-2008.
DR IREN WALZ, postdoc, 2007-2008.
DR MARIA-HÉLÉNA GONÇALVES-FARBOS, postdoc, 2008-2009.
PROFESSOR LUIZ CLAUDIO BARBOSA, sabbatical visitor, 2008-2009. Contact Details: Department of Chemistry, Federal University of Viçosa (UFV), 36570-000 Viçosa - MG - Brazil.
DR NEIL KERSHAW, postdoc 2006-2009.
DR OLIVER WILLIAMS, PhD, 2005-2008. Went on to be a chemist for BP Fuel and Lubricant Technology (Pangbourne).
DR PETE LINDSAY-SCOTT, PhD, 2006-2009. Did a postdoc with K. C. Nicolau and went on to be a medicinal chemist at Lilly.
DR TIM O'RIORDAN, PhD, 2006-2009. Did a postdoc with A. G. M. Barrett and went on to be a medicinal chemist at Syngenta.
DR AIDA FLORES, 2007-2010. Went on to be a Postdoctoral Research Associate at Instituto de Química Médica, CSIC, Madrid.
DR PTOTON MNANGAT, 2006-2009.
DR JOHN BOWER, 2008-2010. Went on to be a Royal Society University Research Fellow at the University of Bristol.
DR MANUEL PEIFER, 2009-2010. Went on to be a postdoc at Princeton.
DR GRÁINNE HARGADEN, 2007-2010. Went on to be a lecturer at the Dublin Institute of Technology.
DR JESS KERSHAW, 2006-2010. Went on to be a patent attorney with Carpmaels and Ransford, London.
DR ADAM LACY, 2008-2011. Did a Postdoc at ETH, Zurich.
DR CEDRIC CALLENS, 2008-2011. Worked as a medicinal chemist at the Institute of Cancer Research.
DR MIKHAIL KABESOV, 2008-2011. Went on to be a postdoctoral researcher at the University of Loughborough
DR STEFANIE MESCH, 2010-2011. Went on to be a medicinal chemist at Novartis
DR MATTHEW CONNOLLY, 2008-2011. Went on to be a postdoctoral researcher at the University of Sheffield.
DR JOSÉ BASUTTO, 2008-2011. Went on to be a postdoc at the University of Canberra.
DR PAUL WINSHIP, 2007-2011. Went on to be a medicinal chemist at the Institute of Cancer Research, London.
DR EMMA WALLACE, 2007-2011. Went on to be a trainee patent attorney at Oxford Nanopore Technologies, Oxford.
DR ALI JAHANSHAHI, 2007-2012. Went on to be an Industry liaison officer at the University of Malaya, Kuala Lumpur.
DR KIRSTY LUSCOMBE, 2009-2012. Went on to be a Development Technologist Infineum, Abingdon.
DR CHRISTIAN WINTER, postdoc, 2010-2012. Went on to be a research scientist (crop protection) with BASF, Germany.
DR RADOSLAW LIPINSKI, PhD, 2008-2012. Went on to be a postdoctoral researcher at the University of Texas at Austin.
DR AKSHAT RATHI, PhD, 2008-2013. Went on to be the Science and Technology editor for The Conversation.
DR ROB PULLIN, postdoc, 2011-2013. Went on to be a medicinal chemist at Vertex Pharmaceutical.
DR LOUIS CHAN, postdoc, 2011-2013. Went on to be a postdoctoral researcher in the Balasubramanian group at the University of Cambridge.
DR BEN PILGRIM, part II and DPhil, 2008-2013. Went on to do a postdoc at the University of Cambridge.
DR CHRIS JONES, postdoc, 2009-2013. Went on to be a research fellow at Queen Mary, University of London.
DR MIKE TUCKER, part II and DPhil, 2008-2013. Went on to be a medicinal chemist at the Institute of Cancer Research, London.
DR DAVID BAKER, PhD, 2010-2014.
DR LEO HARDEGGER, postdoc, 2013-2014. Went on to be a medicinal chemist at Novartis.
DR ANNE KORNAHRENS, PhD, 2011-2014. Returned to Scripps, San Diego, to complete her Skaggs/Oxford DPhil/PhD programme
LENA RAKERS, Visiting Student. Returned to the University of Münster to complete her Masters and PhD programmes.
DR DARREN POOLE, part II and PhD, 2009-2014. Went on to be a medicinal chemist at GlaxoSmithKline.
DR MATTHEW TATTON, PhD, 2010-2014. Went on to be a postdoctoral researcher at Syngenta.
DR ANATOL SPORK, postdoc, 2013-2015. Went on to be a trainee patent lawyer with Uexkell & Stolberg.
DR ALICE GATLAND, part II and PhD, 2010-2015. Went on to be a medicinal chemist for Karus Therapeutics, Abingdon.
DR DI SHEN, PhD, 2011-2015.
DR JACQUELINE HABEGGER, PhD, 2011-2015.
DR EKATERINA MELIKHOVA, PhD, 2012-2016. Went on to be a medicinal chemist CatSci.
DR ROSIMEIRE COURA BARCELOS, postdoc, 2014-2015.
DR XUEZHENG YANG, PhD, 2011-2016. Went on to be a synthetic chemist at Peakdale Molecular.
DR YIFAN LIU, PhD, 2011-2016. Went on to be a strategy manager at Country Garden Properties (Hong Kong) Ltd.
DR HARISH POTUKUCHI, postdoc, 2013-2016. Went on to be a scientific advisor in New Delhi.
DR JOHANNES WALKER, PhD, 2013-2017. Went on to be a postdoc with Prof Martin Oestreich in Berlin.
DR AHRIA ROUSHANBAKHTI, PhD, 2013-2017. Went on to be a trader at Onyx Commodities.
DR SIMON WERREL, PhD, 2013-2017. Went on to be a chemist at BASF.
DR SANDRA BALCELLS GARCIA, PhD, 2013-2017. Went on to be a process chemist at Farmhispania.
DR HENRIQUE ESTEVES, PhD, 2013-2017. Went on to be a postdoc with Prof. Stephen Buchwald at MIT.
DR IGNACIO COLOMER, postdoc 2014-2016. Went on to be a postdoc with Prof. Stephen Fletcher at the University of Oxford.
DR JAMES FROST, postdoc, 2014-2017. Went on to be a medicinal chemist at UCB.
DR HARRY SHIRLEY, postdoc, 2016-2018. Went on to be a editorial development advisor at Nature publishing.
DR CHRIS DELAFORCE, PhD, 2014-2018. Went on to be a data scientist at The Happiness Index.
DR MELODIE RICHARDSON, PhD, 2014-2018. Went on to be a trainee patent attorney at Mewburn Ellis.
DR CHOON BOON CHEONG, PhD, 2014-2018. Went on to be a postdoc with Prof Robert Griffin at MIT.
DR MARIA KOYIONI, postdoc, 2017-2018. Went on to be a postdoc with Prof Piotr Kaszynski at the University of Lodz, Poland.
DR ANNA CHAMBERLAIN, PhD, 2015-2019. Went on to be a trainee patent attorney at Kilburn & Strode.
DR SIMON WUEBBOLT, postdoc 2018-2019. Went on to be a medicinal chemist at Vertex.
DR ALEXANDRU GROZAVU, PhD, 2015-2019. Went on to be a postdoc with Prof Veronique Gouverneur.
DR WASIM AKHTAR, PhD and postdoc, 2014-2019. Went on to be an Analyst at Kraft Heinz Company.
DR HAMISH HEPBURN, postdoc 2017-2020. Went on to be a medicinal chemist at Evotec.
DR YUXIANG ZHU, PhD, 2016-2020. Went on to be a postdoc with Prof John Bower.
DR TIMOTHY KWOK, PhD, 2016-2020. Went on to be a medicinal chemist at Astex.
DR MAXWELL HAUGHEY, PhD, 2016-2020. Went on to be a trainee patent attorney at Carpmaels & Ransford.
DR CHRIS HALL, 2016-2020. Went on to be a trainee patent attorney with Elkington + Fife.
DR OSKAR HOFF, PhD, 2016-2020. Went on to be a medicinal chemist at Celeris.
DR MARVIN KISCHKEWITZ, postdoc 2020-2021. Went on to be a medicinal chemist at LANXESS.
DR ROLY ARMSTRONG, postdoc 2017-2021. Went on to be a Lecturer in Chemistry at Newcastle University.
DR GLENN ARCHIBALD, postdoc 2015-2021. Went on to be an editorial assistant.
DR LEWIS SMITH, PhD, 2018-2022. Went on to be a trainee patent attorney with Elkington + Fife.
DR NICOLAS KRATENA, postdoc, 2020-2022. Went on to be a Research Fellow at TU Wien.
Postdoctoral researchers
DPhil and PhD students
Part II students
